Unlock stock picks and a broker-level newsfeed that powers Wall Street.
3 Asian Penny Stocks With Market Caps Under US$5B

In This Article:

Amidst global economic uncertainties, Asian markets have been navigating a complex landscape influenced by trade tensions and evolving monetary policies. In this context, investors often look beyond established giants to explore opportunities in smaller or newer companies. Penny stocks, though an older term, continue to represent these promising ventures with potential value. This article will explore three such stocks that offer financial stability and growth potential for those interested in tapping into the vibrant world of Asian penny stocks.

Top 10 Penny Stocks In Asia

Name

Share Price

Market Cap

Financial Health Rating

Yangzijiang Shipbuilding (Holdings) (SGX:BS6)

SGD2.38

SGD9.4B

★★★★★☆

Lever Style (SEHK:1346)

HK$1.28

HK$812.53M

★★★★★★

Bosideng International Holdings (SEHK:3998)

HK$4.10

HK$46.99B

★★★★★★

Activation Group Holdings (SEHK:9919)

HK$0.88

HK$655.37M

★★★★★★

Xiamen Hexing Packaging Printing (SZSE:002228)

CN¥3.03

CN¥3.51B

★★★★★★

T.A.C. Consumer (SET:TACC)

THB4.24

THB2.54B

★★★★★★

Beng Kuang Marine (SGX:BEZ)

SGD0.21

SGD41.83M

★★★★★★

China Sunsine Chemical Holdings (SGX:QES)

SGD0.475

SGD452.86M

★★★★★★

Interlink Telecom (SET:ITEL)

THB1.52

THB2.11B

★★★★☆☆

Jiumaojiu International Holdings (SEHK:9922)

HK$3.08

HK$4.3B

★★★★★★

Click here to see the full list of 1,166 stocks from our Asian Penny Stocks screener.

Below we spotlight a couple of our favorites from our exclusive screener.

Brii Biosciences

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Brii Biosciences Limited focuses on developing therapies for infectious and central nervous system diseases in China and the United States, with a market cap of HK$1.48 billion.

Operations: The company's revenue is derived from its Biotechnology (Startups) segment, amounting to CN¥38.38 million.

Market Cap: HK$1.48B

Brii Biosciences, with a market cap of HK$1.48 billion, is currently pre-revenue and unprofitable but has reduced its losses by 41.3% annually over the past five years. The company is debt-free and possesses a cash runway exceeding three years based on current free cash flow trends. Recent volatility in its share price highlights potential risks for investors, although no significant shareholder dilution occurred in the past year. Despite an inexperienced board with an average tenure of 2.5 years, Brii's management team averages 3.3 years of experience, contributing to strategic stability amidst ongoing share repurchase activities aimed at enhancing shareholder value.